PORSHIA MILLER: Open Payments
NPI 1265001531 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,590 in 114 payments from 24 companies in 2025. Trend: 2023 $1,801 · 2024 $1,777 · 2025 $2,590
Food & beverage: $2,440Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 6 | $318 |
| EMD Serono, Inc. | 13 | $290 |
| ABBVIE INC. | 14 | $240 |
| Teva Pharmaceuticals USA, Inc. | 29 | $240 |
| Amgen Inc. | 6 | $231 |
| Biogen, Inc. | 3 | $200 |
| ARGENX US, INC. | 4 | $123 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| Alexion Pharmaceuticals, Inc. | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $107 |
Products named: BRIUMVI, UPLIZNA, AUSTEDO XR, TYSABRI, UBRELVY, KESIMPTA, ULTOMIRIS, HYQVIA.
Industry payments across SC — which companies pay providers there.
